Expanding luminescence-based SBA to 7 Shigella serotypes with Pel-Freez baby rabbit complement
New research addresses the need for Shigellosis vaccine development innovations Shigellosis remains a pressing global health challenge, particularly in low- and middle-income countries where it disproportionately affects children under five. This bacterial infection, caused by Shigella flexneri and other species, is a leading cause of diarrheal mortality and is further complicated by the rise of […]